Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

Prophylactic cranial radiation (PCI) has been shown to reduce the incidence of CNS metastases and prolong survival for patients presenting with limited-stage small cell lung cancer (SCLC). However, concern that such treatment results in cognitive decline has tempered enthusiasm, but this claim has not been satisfactorily addressed.

Prophylactic Cranial Radiation Revisited: Significant Change in Cognitive Function Not Found